827-32-7Relevant articles and documents
KINASE INHIBITORS AND USES THEREOF
-
Paragraph 0817; 0820-0821, (2022/02/15)
Provided are cyclic iminopyridimdine compounds and their bicyclic derivatives, pharmaceutical compositions comprising such compounds, and methods of using such compounds or compositions, such as methods of treating a proliferation disorder, such as a cancer or a tumor, or in some embodiments disease or disorders related to the dysregulation of kinase such as, but not limited to kinases such as MAPK, PDGFR, Src, PAKs, c-Kit, EphA2, EphB4, FGFR, Axl, and c-Met.
SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF
-
Page/Page column 81, (2010/04/03)
The present application relates to novel substituted 5-aminopyrazoles, methods of production thereof, use thereof alone or in combinations for the treatment and/or prophylaxis of diseases and use thereof for the production of medicinal products for the treatment and/or prophylaxis of diseases.
Crystal packing: An examination of the packing of molecules approximately isosteric with 4,5-dichlorophthalic anhydride
Britton, Doyle,Noland, Wayland E.,Pinnow, Matthew J.,Young Jr., Victor G.
, p. 1175 - 1192 (2007/10/03)
The crystal structures of five 5,6-disubstituted benzofurazan 1-oxides are presented and compared with five previously reported structures: three polymorphs of 5,6-dichlorobenzofurazan 1-oxide plus 4,5-dichloro- and 4,5-dibromophthalic anhydride. All but one of these compounds pack with similar two-dimensional layers. The benzofurazan oxides all show disorder about a crystallographic twofold or pseudo-twofold axis. In addition, six complexes of phthalic anhydride and benzofurazan oxides are reported. With the packing in the complexes principally directed by the π complexing, the disorder, invariably found in the uncomplexed benzofurazan oxides, is diminished, and, in two cases, eliminated.